There is now compelling evidence that regulatory T cells (Tregs) suppress immune activation and are perturbed during HIV infection. Exploiting the mechanisms of Treg function is relevant for controlling chronic immune activation during HIV infection or conversely in boosting HIV-specific immune responses. However, several key questions and gaps remain in our understanding of Treg cell biology, especially in the context of HIV pathogenesis. The analysis of Tregs in HIV patients is complicated due to lack of specific markers. It is also still not clear whether Treg cell loss contributes to inflammation during HIV infection or whether they are detrimental by suppressing HIV-specific immune responses. During the previous grant period we made major advances in understanding Treg cell differentiation and established methods to expand them in vitro. We discovered a cell surface molecule, called GARP, highly specifically expressed on bona fide activated Tregs. We also found that receptors for proinflammatory cytokines IL-1 and TNF and their respective decoys are preferentially expressed on human Treg cells. Additionally, we developed a novel technology to expand and genetically engineer Tregs with HIV-specific T cell receptors (TCRs) to determine the role of TCR signals in their suppressive function. In this proposal we aim to use these innovative tools and technical advances to: (1) Determine association of Tregs with immune activation status of HIV-infected individuals either with or without treatment in a prospective study;(2) Determine the function of Tregs in sensing and suppressing inflammation and whether this function is compromised during HIV infection;(3) Determine the specificity and suppressive role of Tregs in manipulating HIV-specific immune responses;and (4) Develop an experimental framework to decode the role of peptide affinity and concentrations in regulating Treg responses through TCR signaling. Together, these new approaches will have wide range of implications for using bona fide Tregs as biomarkers during HIV infection, defining their role in immune activation and in suppressing HIV-specific immune responses during HIV infection. This knowledge can also be exploited to design more potent HIV vaccines.

Public Health Relevance

Chronic immune activation during HIV infection is thought to be a major contributor to development of AIDS. A subset of T cells, regulatory or Tregs, is critical in controlling this chronic immune activation. In this application we propose experiments to understand the contribution of Tregs to HIV disease and their mechanisms of controlling inflammation, which has implications for therapy and vaccine development for HIV/AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI065303-09S1
Application #
8679047
Study Section
Program Officer
Stansell, Elizabeth H
Project Start
2013-08-16
Project End
2015-08-15
Budget Start
2013-08-16
Budget End
2015-08-15
Support Year
9
Fiscal Year
2013
Total Cost
$165,966
Indirect Cost
$68,051
Name
New York University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Khaitan, Alka; Kravietz, Adam; Mwamzuka, Mussa et al. (2016) FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children. J Acquir Immune Defic Syndr 72:474-84
Khaitan, Alka; Kilberg, Max; Kravietz, Adam et al. (2016) HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets. PLoS One 11:e0161786
Kaufmann, Ulrike; Shaw, Patrick J; Kozhaya, Lina et al. (2016) Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function. J Immunol 196:573-85
Vaeth, Martin; Eckstein, Miriam; Shaw, Patrick J et al. (2016) Store-Operated Ca(2+) Entry in Follicular T Cells Controls Humoral Immune Responses and Autoimmunity. Immunity 44:1350-64
Vaeth, Martin; Zee, Isabelle; Concepcion, Axel R et al. (2015) Ca2+ Signaling but Not Store-Operated Ca2+ Entry Is Required for the Function of Macrophages and Dendritic Cells. J Immunol 195:1202-17
Rawlings, Stephen A; Alonzo 3rd, Francis; Kozhaya, Lina et al. (2015) Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency. PLoS One 10:e0126917
Mercer, Frances; Khaitan, Alka; Kozhaya, Lina et al. (2014) Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J Immunol 193:1047-54
Ramesh, Radha; Kozhaya, Lina; McKevitt, Kelly et al. (2014) Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211:89-104
Alonzo 3rd, Francis; Kozhaya, Lina; Rawlings, Stephen A et al. (2013) CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493:51-5
Reyes-Robles, Tamara; Alonzo 3rd, Francis; Kozhaya, Lina et al. (2013) Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14:453-9

Showing the most recent 10 out of 33 publications